Skip to content

Maxele Advisors, LLC: FCOM position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Maxele Advisors, LLC on FCOM, newest first. How the timeline and the estimate are built.

Maxele Advisors, LLC held 19,226 FCOM shares at 2026-06-30 per its 13F-HR filed 2026-08-17.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 19,226 shares
    Change vs previous 13F +6 shares

    0.93% of the 13F portfolio, value $1,335,790.

    13F-HR 0002096567-26-000002 filed by Maxele Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2025-12-31
    13F 19,220 shares
    Change vs previous 13F +28 shares

    1.14% of the 13F portfolio, value $1,408,421.

    13F-HR 0002096567-26-000001 filed by Maxele Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-09-30
    13F 19,192 shares
    Change vs previous 13F -597 shares

    1.17% of the 13F portfolio, value $1,362,074.

    13F-HR 0002096567-25-000001 filed by Maxele Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-06-30
    13F 19,789 shares
    Change vs previous 13F -241 shares

    1.12% of the 13F portfolio, value $1,282,533.

    13F-HR 0002096567-25-000008 filed by Maxele Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-03-31
    13F 20,030 shares
    Change vs previous 13F +138 shares

    1.09% of the 13F portfolio, value $1,126,865.

    13F-HR 0002096567-25-000007 filed by Maxele Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2024-12-31
    13F 19,892 shares
    Change vs previous 13F not available

    1.11% of the 13F portfolio, value $1,167,647.

    13F-HR 0002096567-25-000006 filed by Maxele Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).